When immunohistochemistry for MLH1, MSH2, and PMS2 was performed on primary tumor samples from PCa patients, loss or reduction of MSH2 or PMS2 significantly correlated with Gleason Score ≥ 4 in the entire patient cohort [148]. The gene discussed is MSH2; the disease is neoplasm.